Patients Had Inaccurate Expectations of Well-Being After Mastectomy

Article

Women undergoing mastectomy did not have an accurate idea of their future well-being, with misprediction associated with greater regret but not satisfaction with decisions.

Women undergoing mastectomy did not have an accurate idea of their future well-being, according to the results of a study published in JAMA Surgery. Women who underwent mastectomy without immediate reconstruction underestimated their future well-being and those who did get reconstruction overestimated their well-being.

“Misprediction was associated with greater regret but not with satisfaction with decisions,” wrote Clara Nan-hi Lee, MD, MPP, of the Ohio State University in Columbus, and colleagues. “Decision support for mastectomy and breast reconstruction should address expectations about future well-being.”

The study was designed to help determine how well patients undergoing mastectomy predicted their future well-being. The prospective single-center study included 145 women scheduled to undergo mastectomy for stage 1, 2, or 3 invasive ductal or lobular breast cancer, ductal carcinoma in situ, or prophylaxis.

Preoperative measures included 12-month happiness and quality-of-life prediction, as well as predicted satisfaction with breasts, sexual attractiveness, breast numbness, and pain. At 12 months, participants completed the Decision Regret Scale and Satisfaction With Decisions Scale.

Of the 145 patients surveyed, 131 returned the survey, and 111 of those participants remained at 12 months. Fifteen participants ultimately delayed reconstructive surgery, leaving a final group of 96 women, 54 of whom had no reconstruction.

The mean age of patients was 53.9 years. Those patients who underwent mastectomy with no reconstruction underestimated their future well-being in all measured domains. There were significant differences for both quality of life and satisfaction prediction. For example, patients predicted a mean quality-of-life score of 68 on a scale from 1 to 100, but experienced a mean score of 74.

According to the researchers, the difference was small, but “they may have been large enough to influence decisions.”

In contrast, patients who had reconstruction overestimated future well-being, with significant differences in predicted and actual outcomes for satisfaction with breasts-unclothed, sexual attractiveness-clothed, and sexual attractiveness-unclothed.

“Patients’ expectations of appearance and attractiveness unclothed may be a particularly important aspect of decisions about reconstruction,” the researchers wrote. “The unclothed domains had the largest prediction errors by patients who had mastectomy with reconstruction.”

In addition, a higher percentage of these patients had more severe symptoms than they predicted compared with women who did not undergo reconstruction.

“Importantly, patients undergoing mastectomy without reconstruction anticipated a decline in well-being compared with their baseline scores in every domain, and patients undergoing mastectomy with reconstruction anticipated an improvement in nearly every domain,” the researchers wrote. “We were surprised by patients’ apparent belief that mastectomy with reconstruction would improve appearance over their baseline levels. We speculate that some patients may confuse aesthetic plastic surgery (ie, breast augmentation) with reconstructive plastic surgery.”

Finally, the study showed that those patients who were less happy or had greater pain than they predicted had significantly greater regret.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.